Global Particle Treatment Devices Market Research Report 2021

Particle therapy is a form of external beam radiotherapy using beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy as of 2012 is proton therapy. Additionally, electron therapy is generally put into its own category. Because of this, particle therapy is sometimes referred to, more correctly, as hadron therapy.

The global Particle Treatment Devices market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Particle Treatment Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Particle Treatment Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Particle Treatment Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Proton Treatment Devices
Heavy Ion Treatment Devices

Segment by Application
Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Varian Medical Systems
Ion Beam Applications(IBA)
Mevion Medical Systems
Provision Healthcare
Sumitomo Heavy Industries
Hitachi
Optivus Proton Therapy
Protom International
Advanced Oncotherapy
Danfysik